Guelph, Ontario, Canada
March 17, 2010
Syngenta Crop Protection Canada, Inc. today announced its intent to work with Innovotech (TSX VENTURE:IOT), a Canadian biotechnology product development company, clearing the way for continued research trials in North America on the new plant bacterial blight research product, oxysilver nitrate.
Earlier this year Innovotech and Syngenta entered into a mutually beneficial agreement by which Syngenta will conduct research trials of oxysilver nitrate in a seed treatment application for control of bacterial blight.
"We are very pleased to play a part in the development of this new technology," said Coby Long, North American Seed Care marketing head at Syngenta. "We believe it is important to continually seek out new innovative pest management solutions for producers, both in North America and worldwide."
Bacteria, like fungi, exist in the soil as part of a dynamic agricultural system. Dry beans as well as other crops, can be greatly affected by bacterial diseases. Bacterial blight is a serious problem for many crops with very few acceptable control products available to Canadian producers.
Innovotech is an Edmonton, Alberta-based biotechnology product development company that bases its product line on its unique understanding of biofilms. Currently, Innovotech has products in medical diagnostics and agriculture, and is constantly developing new products or improvements to its existing product lines. For more information please go to www.innovotech.ca.
Syngenta is one of the world's leading companies with more than 25,000 employees in over 90 countries dedicated to our purpose: Bringing plant potential to life. Through world-class science, global reach and commitment to our customers we help to increase crop productivity, protect the environment and improve health and quality of life. For more information about us please go to www.syngenta.com.